Stanford Graduate School of Business (USA)
-
Doctor on Demand
Chess, Robert; Golden, JosephCase SGSB-E703-EEntrepreneurshipThis case considers the state of telehealth, or the remote delivery of healthcare services via telecommunications technology, in 2019. Doctor On Demand, a promising start-up in the space, sought to solve the four main challenges that the telehealth industry had faced historically. First, although most Americans who had health insurance coverage through their employers also received telehealth benefits, very few knew about these services, and an...Starting at €8.20
-
Political Risk in the Kaesong Industrial Complex
Rice, C; Zagart, A; McMurdo, TCase SGSB-IB103-EThe Kaesong Industrial Complex (KIC) is a 1.25-square-mile industrial park six miles north of the Demilitarized Zone in the Democratic People’s Republic of Korea. The complex includes both North and South Korean workers, and is subsidized by Seoul. The result of an agreement between North and South Korea in 2000, Kaesong stood as the sole beacon of hope for economic cooperation between the divided states, and remained open for business despite a...Starting at €8.20
-
Invitrogen (A)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209A-EStrategyFounded in 1987, Invitrogen was one of the largest catalog life science companies in the industry. Its customers came from academic research, biotechnology and pharmaceutical companies and government laboratories. Scientists viewed Invitrogen as a one-stop shop for all major molecular biology, biochemistry and cell culture reagent products, with prices ranging from a hundred dollars to a few thousand dollars.Starting at €8.20
-
Invitrogen/Life Technologies (B)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209B-EStrategyOn June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.Starting at €5.74
-
San Leon Energy: Hydraulic Fracturing in Poland
Rice, C; Zagart, A; Myers, ACase SGSB-IB101-EThis case explores how to manage the political risks of using a controversial energy extraction technology in the European Union. San Leon Energy, an Irish energy firm, was committed to developing large unconventional shale gas reserves in Poland. To reach these reserves, San Leon needed to use a technique called hydraulic fracturing (“fracking”). Pioneered in the United States during the early 2000s, fracking involved pumping a mixture of water...Starting at €8.20
-
Engyn in Iraq: Choosing Between Baghdad and Erbil
Rice, C; Zagart, A; Nicas, CCase SGSB-IB102-EWhen the Iraqi Oil Ministry held its first licensing round after the fall of Saddam Hussein, more known oil reserves were put up for bid than at any other moment in history. Allured by the opportunity, the chief executive of Engyn Oil & Gas (a fictional firm) began exploring ways to enter the Iraqi market. The CEO soon discovered that the endeavor was fraught with risks. The biggest political minefield was the long running power-sharing disput...Starting at €8.20
-
MedAvante: Navigating Resistance to Innovation
Foster, George; Golden, JosephCase SGSB-E676-EEntrepreneurshipMedAvante, a provider of clinical trial services and technology solutions to the pharmaceutical industry, struggled to find product/market fit for many years, because its innovative service offering met fierce resistance from other stakeholders in the ecosystem. A strategic pivot to work with the ecosystem, not against it, saved the company and brought its co-founders to the brink of a successful exit. This case explores the difficulties of bri...Starting at €8.20
-
Invitrogen/Life Technologies (C): The "Best Owner" of the Asset
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209C-EStrategyThis short case discusses the process of Life Technologies’ acquisition by Thermo Fisher in 2013 and 2014. The case is a complement to SM-209A and SM-209B, which highlight the various growth and acquisition strategies the company undertook over the previous 10 years.Starting at €5.74
-
Waste Concern in Dhaka: Scaling a Model for Urban Waste Management
Callendar, Steven; Golden, Joseph; Kavanaugh, BlakeCase SGSB-P104-EBusiness Ethics and Corporate Social ResponsibilityIn March 2006, Iftekhar Enayetullah and Abu Hasnat Md. Maqsood Sinha, the cofounders of Waste Concern, a social enterprise based in Dhaka, Bangladesh, and focused on developing innovative waste management solutions for cities in emerging Asia, faced their biggest challenge yet: scaling up their organization’s activities and impact. The previous fall, working with a Dutch recycling firm, Waste Concern had secured approval from the United Nations ...Starting at €8.20
-
Venus Medtech: Global Innovation in the Race Between China and the USA
Ziebelman, Peter; Golden, JosephCase SGSB-E693-EEntrepreneurshipThe main purpose of the Venus Medtech case is to give students a greater appreciation for the scale, sophistication, and competitiveness of the innovation landscape outside of Silicon Valley, with particular focus on China. Through a dramatized account of the June 2013 Series A fundraising experience of Venus Medtech, a Chinese medical device start-up, the case forms the basis of a rich, in-class discussion about the similarities and differences...Starting at €8.20